BRGX Bioregenx, Inc.

Fundamentals / CIK 0001593184 / USD

Bioregenx, Inc. reported $1.77M in revenue and a net loss of $1.30M for the trailing twelve months ended March 31, 2026 (down 17.3% year over year), with a 81.9% gross margin and a -62.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BRGX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

5 fiscal years (2021 to 2025), reported in USD.

$5.80M$2.90M$0-$21.85MFY 2021 Revenue: $199KFY 2021 Net Income: -$97K2021FY 2022 Revenue: $42KFY 2022 Net Income: -$78K2022FY 2023 Revenue: $3.41MFY 2023 Net Income: -$3.60M2023FY 2024 Revenue: $2.34MFY 2024 Net Income: -$23.05M2024FY 2025 Revenue: $1.85MFY 2025 Net Income: -$1.54M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.85M $2.34M $3.41M $42K $199K
Cost of Revenue $351K $682K $1.10M $0 $554
Gross Profit $1.50M $1.66M $2.31M $42K $198K
Research & Development $32K $0 $258K -- --
Selling, General & Admin $2.01M $5.85M $5.23M -- --
Total Operating Expenses $2.75M $24.42M $5.72M $120K $363K
Operating Income -$1.24M -$22.76M -$3.41M -$78K -$165K
EBITDA -$1.17M -$20.54M -$3.40M -- --
Interest Expense $300K $291K $292K $0 --
Income Before Tax -- -- -$571K -$78K -$97K
Income Tax Expense -- -- $0 $0 $0
Net Income -$1.54M -$23.05M -$3.60M -$78K -$97K
Basic EPS $0.00 -$0.03 -$0.01 $0.00 $0.00
Diluted EPS $0.00 -$0.03 -$0.01 $0.00 $0.00
Basic Shares Outstanding 959.7M 912.4M 639.8M 269.7M 269.7M
Diluted Shares Outstanding 959.7M 912.4M 639.8M 269.7M 269.7M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue $426K $386K $508K $446K $515K $460K $596K $734K
Cost of Revenue $78K $67K $81K $94K $109K $138K $114K $264K
Gross Profit $348K $319K $426K $352K $406K $323K $482K $470K
Research & Development -- $32K $0 $0 $0 -$15K $0 $7.5K
Selling, General & Admin $396K $552K $433K $457K $590K $1.87M $236K $1.40M
Total Operating Expenses $398K $1.25M $435K $460K $599K $18.64M $809K $1.51M
Operating Income -$50K -$936K -$8.5K -$107K -$193K -$18.32M -$327K -$1.04M
EBITDA -$37K -- $3.9K -$70K -$180K -$17.74M -$315K -$1.03M
Interest Expense $77K $82K $72K $71K $74K $3.7K $68K $66K
Net Income -$26K -$1.02M -$81K -$178K -$267K -$18.40M -$395K -$1.11M
Basic EPS $0.00 -- $0.00 $0.00 $0.00 -- $0.00 $0.00
Diluted EPS $0.00 -- $0.00 $0.00 $0.00 -- $0.00 $0.00
Basic Shares Outstanding 969.2M -- 960.9M 959.2M 957.0M -- 956.5M 956.5M
Diluted Shares Outstanding 969.2M -- 960.9M 959.2M 957.0M -- 956.5M 956.5M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $69K $58K $125K $676 $24K
Cash & Short-Term Investments $69K $58K $125K $676 $24K
Accounts Receivable, Net $40K $15K $105K -- --
Inventory $107K $111K $218K -- --
Other Current Assets $30K $118K $143K -- --
Total Current Assets $251K $308K $653K $676 $24K
Property, Plant & Equipment, Net $160K $201K $14K -- --
Goodwill -- -- $0 -- --
Intangible Assets -- $0 $49K $37K $43K
Other Non-Current Assets -- $0 $150K -- --
Total Non-Current Assets $160K $201K $32K $58K $103K
Total Assets $411K $509K $866K $59K $128K
Accounts Payable $616K $427K $242K -- --
Short-Term Debt $1.00M $883K $200K $4.2K $2.2K
Deferred Revenue (Current) $60K $197K $354K -- --
Total Current Liabilities $4.07M $3.63M $2.79M $65K $14K
Long-Term Debt $182K $255K $0 $196K $198K
Total Non-Current Liabilities $882K $255K $150K $196K $198K
Total Liabilities $4.95M $3.89M $2.94M $261K $212K
Total Debt (incl. Leases) $1.19M $1.14M $200K $200K $200K
Common Stock $969K $957K $771K $270K $270K
Retained Earnings -$37.12M -$35.57M -$12.52M -$2.92M -$2.80M
Accumulated Other Comp. Income $0 $2.0K -$942 -- --
Total Stockholders' Equity -$4.54M -$3.38M -$2.07M -$2.53M -$84K
Total Equity -$4.54M -$3.38M -$2.07M -$2.53M -$84K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $46K $69K $47K $46K $84K $58K $70K $57K
Cash & Short-Term Investments $46K $69K $47K $46K $84K $58K $70K $57K
Accounts Receivable, Net $18K $40K $63K $21K $11K $15K $19K $11K
Inventory $93K $107K $109K $134K $140K $111K $159K $144K
Other Current Assets $28K $30K $49K $43K $54K $118K $73K $109K
Total Current Assets $190K $251K $273K $250K $294K $308K $371K $326K
Property, Plant & Equipment, Net $147K $160K $170K $176K $188K $201K $213K $225K
Goodwill -- -- -- -- -- -- $7.11M $7.11M
Intangible Assets -- -- $725K $725K -- $0 $9.67M $10.23M
Other Non-Current Assets -- -- -- -- -- $0 $0 $0
Total Non-Current Assets $147K $160K $895K $901K $188K $201K $16.99M $17.56M
Total Assets $337K $411K $1.17M $1.15M $483K $509K $17.36M $17.89M
Accounts Payable $699K $616K $460K $569K $491K $427K $493K $432K
Short-Term Debt -- $1.00M -- -- -- $883K -- --
Deferred Revenue (Current) $57K $60K $96K $125K $189K $197K $166K $196K
Total Current Liabilities $3.99M $4.07M $3.93M $3.93M $3.78M $3.63M $3.52M $3.42M
Long-Term Debt -- $182K -- -- -- $255K -- --
Total Non-Current Liabilities $883K $882K $881K $880K $257K $255K $282K $250K
Total Liabilities $4.87M $4.95M $4.81M $4.81M $4.04M $3.89M $3.80M $3.67M
Total Debt (incl. Leases) -- $1.19M -- -- -- $1.14M -- --
Common Stock $972K $969K $962K $961K $960K $957K $957K $957K
Retained Earnings -$37.14M -$37.12M -$36.10M -$36.02M -$35.84M -$35.57M -$17.17M -$16.78M
Accumulated Other Comp. Income -- $0 -- -$7.2K -$25 $2.0K -$1.9K $618
Total Stockholders' Equity -$4.53M -$4.54M -$3.65M -$3.65M -$3.56M -$3.38M $13.56M $14.22M
Total Equity -$4.53M -$4.54M -$3.65M -$3.65M -$3.56M -$3.38M $13.56M $14.22M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$1.54M -$23.05M -$3.60M -$78K -$97K
Depreciation & Amortization $75K $2.22M $4.8K -- --
Stock-Based Compensation $0 $2.85M $2.24M -- --
Change in Receivables -$25K $90K -$21K $0 $971
Change in Inventory $4.2K $106K -$36K -- --
Operating Cash Flow $39K -$324K -$1.52M -$65K -$120K
Capital Expenditure -$9.1K -$189K $0 -- --
Free Cash Flow $30K -$514K -$1.52M -- --
Investing Cash Flow -$59K -$188K -$199K $0 $0
Common Stock Issued -- $0 $1.34M -- --
Financing Cash Flow $33K $442K $1.20M $41K $50K
Net Change in Cash $11K -$67K -$491K -$24K -$70K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income -$26K -$1.02M -$81K -$178K -$267K -$18.40M -$395K -$1.11M
Depreciation & Amortization $13K -- $12K $37K $12K $574K $12K $7.6K
Stock-Based Compensation $6.8K $0 $0 $0 $0 $1.36M -$331K $173K
Change in Receivables $21K $23K -$41K -$10.0K $3.8K $4.5K -$8.5K $232
Change in Inventory $14K $2.4K $25K $6.2K -$29K $48K -$15K $69K
Operating Cash Flow $27K $70K -$72K $3.2K $38K -$11K -$31K -$177K
Capital Expenditure -- -$3.1K -$6.0K $0 $0 $0 $0 $0
Free Cash Flow -- $67K -$78K $3.2K $38K -$11K -$31K -$177K
Investing Cash Flow -- -$3.1K -$6.0K -$50K $0 $2.7K $0 $0
Financing Cash Flow -$50K -$44K $71K $17K -$10K -$6.9K $46K $120K
Net Change in Cash -$24K $22K $491 -$37K $25K -$12K $13K -$57K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 81.1% 70.9% 67.8% 100.0% 99.7%
Operating Margin -67.1% -972.7% -99.9% -185.7% -83.1%
Net Profit Margin -83.2% -985.2% -105.5% -185.7% -48.8%
Return on Assets (ROA) -375.6% -4533.4% -415.8% -132.4% -75.8%
Current Ratio 0.06x 0.08x 0.23x 0.01x 1.72x
Quick Ratio 0.04x 0.05x 0.16x 0.01x 1.72x
Revenue Growth (YoY) -20.8% -31.4% +7991.8% -78.8% --
Gross Profit Growth (YoY) -9.3% -28.3% +5382.6% -78.7% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Gross Margin 81.9% 81.1% 78.1% 77.5% 72.9% 70.9% -- --
Operating Margin -62.4% -67.1% -965.4% -938.9% -862.1% -972.7% -182.1% -246.7%
Net Profit Margin -73.8% -83.2% -981.0% -953.6% -874.7% -985.2% -192.0% -255.2%
Return on Equity (ROE) -- -- -- -- -- -- -36.2% -49.5%
Return on Assets (ROA) -386.6% -375.6% -1620.7% -1672.3% -4178.9% -4533.4% -28.3% -39.3%
Current Ratio 0.05x 0.06x 0.07x 0.06x 0.08x 0.08x 0.11x 0.10x
Quick Ratio 0.02x 0.04x 0.04x 0.03x 0.04x 0.05x 0.06x 0.05x
Revenue Growth (YoY) -17.3% -16.3% -14.8% -39.2% -6.3% -32.1% -25.0% -15.0%
Gross Profit Growth (YoY) -14.2% -1.2% -11.5% -25.0% +5.7% -- -15.7% -21.5%
Operating Cash Flow Growth (YoY) -29.4% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001593184) · from December 31, 2021 Data through March 31, 2026 · synced Nov 21, 2026, 05:16 UTC · Open in terminal